Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis

References

• Agarwal R, Katare OP, Vyas SP. 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 228:43–52.
   PubMed Web of Science ®Google Scholar
• Agrawal U, Gupta M, Dube D, Vyas SP. 2012. Options and opportunities for clinical management and treatment of psoriasis. Crit Rev Ther Drug Carr Sys. 29:149–182.
   PubMedGoogle Scholar
• Agrawal Y, Petkar KC, Sawant KK. 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 401:93–102.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 59:478–490.
   PubMed Web of Science ®Google Scholar
• Chhabra N, Aseri ML, Goyal V, Sankhla S. 2012. Capsaicin: a promising therapy – A critical reappraisal. Int J Nut Pharmacol Neurolog Dis. 2:8–15.
   Google Scholar
• Das S, Ng WK, Tan RB. 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?Eur J Pharm Sci. 47:139–151.
   PubMed Web of Science ®Google Scholar
• Demerjian M, Mao MQ, Choi EH, Brown BE, Crumrine D, Chang S, et al. 2006. Topical treatment with thiazolidinediones, activators of peroxisome proliferators-activated receptor-c, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol. 15:154–160.
   PubMed Web of Science ®Google Scholar
• Desai PR, Marepally S, Patel AR, Voshavar C, Chaudhuri A, Singh M. 2013. Topical delivery of anti-TNFαsiRNA and capsaicinvianovel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. J Control Release doi:10.1016/j.jconrel.2013.04.021.
   Web of Science ®Google Scholar
• El Maghraby GM, Barry BW, Williams AC. 2008. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci. 34: 203–222.
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. 2008. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 70:633–640.
   PubMed Web of Science ®Google Scholar
• Gupta M, Agrawal U, Vyas SP. 2012. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Exp Opin Drug Del7: 783–804.
   Google Scholar
• Gupta M, Tiwari S, Vyas SP. 2011. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Technol. doi:10.3109/10837450.2011.598161.
   Web of Science ®Google Scholar
• Gupta M, Vyas SP. 2012. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phy Lip. 165:454–461.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. 2005. Preparation and char-acterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces. 45:167–173.
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. 2008. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 346:124–132.
   PubMed Web of Science ®Google Scholar
• Knudsen N, Rønholt S, Salte RD, Jorgensen L, Thormann T, Basse LH, et al. 2012. Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm. 81:532–539.
   PubMed Web of Science ®Google Scholar
• Lin Y, Zih-Rou H, Rou-Zi Z, Fang J. 2010. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed. 5:117–128.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. 2007. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 328:191–195.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Bowcock AM, Krueger JG. 2007. Pathogenesis and therapy of psoriasis. Nature. 445:866–873.
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Koskinen LD. 2000. In vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responses. Int J Pharm. 195:55–62.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Muller RH. 2009. Lipid nanoparticles (SLN vs NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 366:170–184.
   PubMed Web of Science ®Google Scholar
• Qingzhi LV, Aihua Y, Yanwei X, Houli L, Zhimei S, Jing C, et al. 2009. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 372:191–198.
   PubMed Web of Science ®Google Scholar
• Raza K, Katare OP, Setia A, Bhatia A, Singh B. 2012. Improved therapeutic perform-ance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul. doi:10.3109/02652048.2012.717115.
   PubMed Web of Science ®Google Scholar
• Shah AK, Date AA, Joshi MD, Patraval VB. 2007. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 345:163–171.
   PubMed Web of Science ®Google Scholar
• Song Y, Kim C. 2006. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials. 27:271–280.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. 2004. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278:71–77.
   PubMed Web of Science ®Google Scholar
• Teichmann A, Heuschkel S, Jacobi U, Presse G, Neubert RHH, Sterry W, Lademann J. 2007. Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm. 66:159–164.
   PubMed Web of Science ®Google Scholar
• Vobalaboina V, Kopparam M. 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release95:627–638.
   PubMed Web of Science ®Google Scholar
• Weyenberg W, Filev P, Van den Plas D, Vandervoort J, DeSmet K, Sollie P, Ludwig A. 2007. Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int J Pharm. 337:291–298.
   PubMed Web of Science ®Google Scholar
• Yu C. 2011. Study on HIF-1α gene translation in psoriatic epidermis with the topical treatment of capsaicin ointment. ISRN Pharm. 821874. doi:10.5402/2011/821874.
   Google Scholar
• Zakir F, Vaidya B, Goyal AK, Malik B, Vyas SP. 2010. Development and char-acterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Deliv. 17:238–248.
   PubMed Web of Science ®Google Scholar